Research indicates that approximately 45 individuals in the United Kingdom could die daily from heart disease linked to excess weight over the next decade if current trends persist. Cardiovascular disease remains the UK's leading cause of mortality, with around 200,000 people annually experiencing heart attacks or strokes. Despite some countries seeing a plateau in obesity rates, the UK continues to witness an increase, particularly among young people.
Obesity incurs costs exceeding £6.5 billion annually for the National Health Service (NHS) and is a primary driver of preventable ill health, elevating the risk of heart attack, stroke, and cancer. The British Heart Foundation (BHF) is advocating for the government to implement its promised "healthy food revolution."
"We are at risk of sleepwalking further into an obesity epidemic which will have dire consequences for decades to come," stated Dr. Charmaine Griffiths, the BHF's CEO. "Obesity is one of the biggest drivers of cardiovascular disease, so if we don't keep momentum, there could be tens of thousands of families who will lose loved ones needlessly over the next decade. These deaths are not inevitable. Bold action now by the UK Government could mean preventing more lives being cut short by obesity."
Cardiovascular deaths among working-age adults in the UK have seen an 18% rise since 2019, increasing from 18,693 to 21,975 in 2023, averaging 420 deaths per week. Approximately one in nine cardiovascular deaths in England each year is attributed to excess weight and obesity, largely driven by poor dietary choices. High levels of deprivation and significant inequalities across the country are also cited as contributing factors, with high-fat, high-salt, and high-sugar foods being more accessible than healthier alternatives.
Dr. Griffiths emphasized the urgency, noting, "The Government has promised a ‘healthy food revolution,’ but it’s yet to materialise. Pledges must become policy sooner rather than later if we’re to stop heart attacks and strokes robbing thousands of the chance to live a long, healthy life." The policy was announced last year, but a formal consultation has yet to be published, intensifying concerns about the dwindling time to address the obesity crisis.
Katharine Jenner, Executive Director of the Obesity Health Alliance, added, "We cannot accept a future where tens of thousands more lives are cut short, unnecessarily, by diet-related disease. On the one-year anniversary of the Healthy Food Standards being announced, these stark projections should serve as a reminder to the government of the urgent need to act. Strong targets for businesses to improve the healthiness of the food they sell would help shift the balance towards healthier products and reduce diet-related disease across the population."
Approximately eight million people in the UK are estimated to live with cardiovascular disease. An estimated 1.2 million have a body mass index (BMI) above 27, classifying them as clinically overweight or obese. Excess weight, particularly abdominal fat, contributes to cholesterol buildup in arteries, increasing the risk of high cholesterol, elevated blood pressure, and type 2 diabetes, all of which strain the heart. Blockages in major arteries can lead to heart attacks, strokes, or dementia.
The BHF has called for government initiatives to prevent 125,000 heart attacks and strokes, reduce early cardiovascular disease deaths by 25%, and cut years lost to heart-related ill health by a quarter by 2035. In addition to promoting healthier diets, weight loss medications are being explored as a potential intervention. Earlier this year, the NHS announced plans to offer weight loss jabs, such as semaglutide (Wegovy and Ozempic), to 1.2 million patients with a BMI over 27 to help prevent heart attacks and strokes. Clinical trials have shown these drugs can reduce the risk of heart attack or stroke by 20% by acting directly on the circulatory system. Helen Williams, national clinical director for cardiovascular disease prevention at NHS England, described the treatment as potentially "life-changing" for over a million high-risk individuals.